Roth DA - Search Results

1

Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus.

Arends EJ, Zlei M, Tipton CM, Cotic J, Osmani Z, de Bie FJ, Kamerling SWA, van Maurik A, Dimelow R, Gregan YI, Fox NL, Rabelink TJ, Roth DA, Sanz I, van Dongen JJM, van Kooten C, Teng YKO. Arends EJ, et al. Among authors: roth da. Rheumatology (Oxford). 2024 Sep 1;63(9):2387-2398. doi: 10.1093/rheumatology/keae286. Rheumatology (Oxford). 2024. PMID: 38775637 Free PMC article.

2

Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.

Struemper H, Murtaugh T, Gilbert J, Barton ME, Fire J, Groark J, Fox NL, Roth D, Gordon D. Struemper H, et al. Clin Pharmacol Drug Dev. 2016 May;5(3):208-15. doi: 10.1002/cpdd.219. Epub 2015 Dec 4. Clin Pharmacol Drug Dev. 2016. PMID: 27163500 Free PMC article. Clinical Trial.

3

Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus .

Sheikh SZ, Hammer AE, Fox NL, Groark J, Struemper H, Roth D, Gordon D. Sheikh SZ, et al. Int J Clin Pharmacol Ther. 2016 Nov;54(11):914-922. doi: 10.5414/CP202623. Int J Clin Pharmacol Ther. 2016. PMID: 27668697 Free PMC article.

4

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Stohl W, et al. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.

5

Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.

Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer AE, Groark J, Bass D, Fox NL, Roth D, Gordon D. Doria A, et al. Arthritis Rheumatol. 2018 Aug;70(8):1256-1264. doi: 10.1002/art.40511. Epub 2018 Jun 15. Arthritis Rheumatol. 2018. PMID: 29671280 Free PMC article. Clinical Trial.

6

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial.

Tanaka Y, Bass D, Chu M, Egginton S, Ji B, Struemper H, Roth D. Tanaka Y, et al. Mod Rheumatol. 2019 May;29(3):452-460. doi: 10.1080/14397595.2018.1480915. Epub 2018 Jul 20. Mod Rheumatol. 2019. PMID: 29792370 Clinical Trial.

7

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus.

Doria A, Bass D, Schwarting A, Hammer A, Gordon D, Scheinberg M, Fox NL, Groark J, Stohl W, Kleoudis C, Roth D. Doria A, et al. Lupus. 2018 Aug;27(9):1489-1498. doi: 10.1177/0961203318777634. Epub 2018 May 28. Lupus. 2018. PMID: 29807477 Free PMC article. Clinical Trial.

8

Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial.

Tanaka Y, Bass D, Chu M, Egginton S, Ji B, Roth D. Tanaka Y, et al. Mod Rheumatol. 2020 Mar;30(2):313-320. doi: 10.1080/14397595.2019.1630897. Epub 2019 Jul 4. Mod Rheumatol. 2020. PMID: 31199180 Clinical Trial.

9

Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension.

van Vollenhoven RF, Navarra SV, Levy RA, Thomas M, Heath A, Lustine T, Adamkovic A, Fettiplace J, Wang ML, Ji B, Roth D. van Vollenhoven RF, et al. Rheumatology (Oxford). 2020 Feb 1;59(2):281-291. doi: 10.1093/rheumatology/kez279. Rheumatology (Oxford). 2020. PMID: 31302695 Free PMC article. Clinical Trial.

10

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.

Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, Amoura Z, Yu X, Mok CC, Santiago MB, Saxena A, Green Y, Ji B, Kleoudis C, Burriss SW, Barnett C, Roth DA. Furie R, et al. Among authors: roth da. N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180. N Engl J Med. 2020. PMID: 32937045 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters